TRG Natural Pharmaceuticals owes creditors more than $1.2m
Founder of honey biotech firm placed the company into liquidation late last year, much to the surprise of small shareholders.
TRG Natural Pharmaceuticals develops medical products for skin conditions, pain, nutrition, and cosmetics from kānuka honey.
Failed honey biotech firm TRG Natural Pharmaceuticals owes creditors more than $1.2 million, according to the liquidators’ first report.
The Tauranga-based company was placed into liquidation at the request of its second-largest shareholder, Shaun Holt, on December 18.
Holt founded the company,
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Yearly Premium Online Subscription
NZ$499.00 / yearly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly
credit card debit
Premium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly
credit card debit
Premium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly
credit card debit
Premium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly
credit card debit
Yearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Individual
Group membership
NBR Marketplace
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
